Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.37 |
| ▸ | BLM | P54132 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.37 |
| ▸ | GMNN | O75496 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | APEX1 | P27695 | 2/20 | 0.37 |
| ▸ | RECQL | P46063 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | TERT | O14746 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | FABP4 | P15090 | 2/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.35 |
| ▸ | PPARG | P37231 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18092328 | 1.00 | FAAH (0.39) | FAAHTRPV1TSHRCYP1A2CYP2C19 | |
| SCHEMBL31679616 | 0.84 | — | — | |
| SCHEMBL17017282 | 0.84 | — | — | |
| SCHEMBL18092326 | 0.80 | FAAH (0.45) | FAAHTRPV1CYP1A2CYP2C19BLM | |
| SCHEMBL21551898 | 0.80 | FAAH (0.45) | FAAHTRPV1CYP1A2CYP2C19BLM | |
| SCHEMBL18092325 | 0.80 | FAAH (0.45) | FAAHTRPV1CYP1A2CYP2C19BLM | |
| SCHEMBL9875996 | 0.78 | — | — | |
| SCHEMBL9875993 | 0.78 | — | — | |
| SCHEMBL28949753 | 0.77 | TSHR (0.37) | TSHR | |
| SCHEMBL14496881 | 0.76 | LPAR2 (0.45) | FAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9708236-B2 | Terminal alkene monoisomerization catalysts and methods | SAN DIEGO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2017-07-18 | — | — | US | disclosed |
| US-9708236-B2 | Terminal alkene monoisomerization catalysts and methods | SAN DIEGO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2017-07-18 | — | — | US | disclosed |
| US-20150231621-A1 | TERMINAL ALKENE MONOISOMERIZATION CATALYSTS AND METHODS | SAN DIEGO STATE UNIVERSITY RESEARCH FOUNDATION | 2015-08-20 | — | — | US | disclosed |
| US-20150231621-A1 | TERMINAL ALKENE MONOISOMERIZATION CATALYSTS AND METHODS | SAN DIEGO STATE UNIVERSITY RESEARCH FOUNDATION | 2015-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150231621-A1 | TERMINAL ALKENE MONOISOMERIZATION CATALYSTS AND METHODS | INF2, CPNE4, TEC | FAAH 1507/4885TRPV1 2795/4885TSHR 3666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.